Searched for
INDIAN SERUM INSTITUTE
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...- Travel insurance versus overseas student health cover: What Indian students need to knowIndian students studying in Australia must secure Overseas Student Health Cover (OSHC) for visa compliance and medical needs. While not man...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...
- Ebola at the gates: Why India must not let its guard downIndia is enhancing its surveillance protocols following an Ebola outbreak in the Democratic Republic of Congo and Uganda. One of two suspec...
- Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- IPL may become the GOAT of sports world; League sees sharp rise in valuations on record media rights deals, deep-pocketed sponsorsIPL franchise values are soaring, projected to hit $15 billion by 2032. This growth rivals top European football clubs. Record media rights...
- Rajasthan Royals sold for $1.65B to Mittal-Poonawalla consortiumA consortium led by the Mittal family and including Adar Poonawalla will acquire Rajasthan Royals for $1.65 billion. The Mittal family will...
- Oxford University strikes new malaria vaccine pact with Serum Institute of IndiaOxford University and Serum Institute of India are collaborating on a new malaria vaccine, R78C. This partnership aims to create a more eff...
- Adar Poonawalla to buy London property for Rs 1,440 crore, the second-most expensive ever soldIndian billionaire Adar Poonawalla is set to purchase a London mansion, Aberconway House, for £138 million (Rs 1,440 crore), marking the ci...
- India's Serum to double investment in Biocon's unit to $300 mlnSerum Institute of Life Sciences is a unit of Serum Institute of India, the world's biggest vaccine maker. Under new terms of the alliance,...
- Biocon Biologics, Serum Institute Life Sciences to expand tie-up for R&D, new vaccinesOn Thursday, Biocon had said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about Rs3...
- India pulled back global supply of COVAX due to surge of cases inside the country: USAID administrator"When the Delta variant is raging around the world and supply is lacking globally because the Serum Institute of India pulled back hundreds...
- Ukraine in talks with India on COVID-19 vaccine supply: Interfax"Negotiations are underway with an Indian manufacturer, Serum Institute, which can produce the American Novovax vaccine and has the ability...
- India wants Serum Institute to lower price of AstraZeneca's Covid-19 vaccineSenior officials have been discussing the terms of the deal with the Serum Institute for weeks, hoping to bring down prices below $3 per sh...
- Govt panel recommends marketing authorisation to Serum Institute’s Covishield vaccine"The Subject Expert Committee has recommended in favour of marketing authoritsation to SII’s vaccine but with certain conditions, a person ...
- Serum Institute likely to supply Covid vaccine at Rs 250 a dose to the government: Media reportsThe government is pinning its hopes for mass supply on Serum Institute, which lodged the first formal application for emergency-use approva...
- Serum Institute to focus on supplying COVID-19 vaccine to India firstPoonawalla's comments came shortly after AstraZeneca said on Monday its vaccine could be around 90% effective, giving the world's fight aga...
- Serum Institute hikes stake in Panacea Biotec to 7%India’s largest vaccine maker, Serum Institute of India, has picked up close to 7% stake in rival firm Panacea Biotec.
Load More
